Max Healthcare Institute Ltd

Max Healthcare Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Max Healthcare Institute Ltd

₹ 1,008 1.72%
17 Apr - close price
maxhealthcare.in BSE: 543220 NSE: MAXHEALTH
About

Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]

Key Points

Leadership[1]
The company is India’s largest hospital chain in terms of market cap and 2nd largest hospital in terms of revenue and EBITDA.

Website BSE NSE
  • Market Cap ₹ 98,064 Cr.
  • Current Price ₹ 1,008
  • High / Low ₹ 1,314 / 903
  • Stock P/E 67.2
  • Book Value ₹ 103
  • Dividend Yield 0.15 %
  • ROCE 14.9 %
  • ROE 12.7 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 80.5% CAGR over last 5 years

Cons

  • Stock is trading at 9.75 times its book value
  • Company has a low return on equity of 13.9% over last 3 years.
  • Company might be capitalizing the interest cost

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
1,142 1,215 1,285 1,363 1,335 1,423 1,543 1,707 1,868 1,910 2,028 2,135 2,068
828 874 948 976 949 1,041 1,156 1,257 1,369 1,398 1,505 1,560 1,529
Operating Profit 314 340 337 387 386 382 387 451 499 512 523 575 538
OPM % 28% 28% 26% 28% 29% 27% 25% 26% 27% 27% 26% 27% 26%
45 40 41 45 46 45 35 41 -40 47 37 33 -3
Interest 20 20 19 9 11 21 24 34 52 55 55 54 60
Depreciation 57 60 56 58 61 70 77 84 98 101 104 108 111
Profit before tax 281 301 303 366 360 336 321 374 309 402 400 446 365
Tax % 21% 17% 21% 24% 20% 25% 26% 25% 23% 21% 23% -10% 17%
222 251 240 277 289 252 236 282 239 319 308 491 301
EPS in Rs 2.29 2.58 2.47 2.85 2.98 2.59 2.43 2.90 2.46 3.28 3.17 5.05 3.09
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
1,608 1,729 1,691 1,059 2,508 3,937 4,563 5,406 7,028 8,140
1,467 1,616 1,535 965 2,101 2,986 3,322 3,913 5,180 5,992
Operating Profit 141 113 156 94 407 951 1,241 1,493 1,849 2,148
OPM % 9% 7% 9% 9% 16% 24% 27% 28% 26% 26%
59 65 56 48 -122 110 139 177 82 113
Interest 100 99 101 83 179 101 84 60 165 224
Depreciation 96 94 103 46 174 221 232 245 359 424
Profit before tax 5 -15 8 13 -69 739 1,064 1,365 1,406 1,614
Tax % -236% 65% 102% -1% 67% 18% -4% 23% 24%
16 -25 -0 59 -138 605 1,104 1,058 1,076 1,419
EPS in Rs 0.29 -0.47 -0.06 1.10 -1.42 6.24 11.37 10.88 11.07 14.59
Dividend Payout % 0% 0% 0% 0% 0% 0% 9% 14% 14%
Compounded Sales Growth
10 Years: %
5 Years: 46%
3 Years: 21%
TTM: 24%
Compounded Profit Growth
10 Years: %
5 Years: 81%
3 Years: 23%
TTM: 38%
Stock Price CAGR
10 Years: %
5 Years: 34%
3 Years: 29%
1 Year: -7%
Return on Equity
10 Years: %
5 Years: 12%
3 Years: 14%
Last Year: 13%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 537 537 537 537 966 970 971 972 972 972
Reserves 655 627 426 2,016 4,673 5,313 6,439 7,436 8,409 9,080
874 981 1,003 875 1,101 913 689 1,299 3,010 3,275
1,080 1,157 1,389 546 1,803 1,993 2,003 2,293 2,795 2,954
Total Liabilities 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000 15,186 16,281
2,244 2,227 2,192 851 6,536 7,018 7,039 8,784 11,502 11,826
CWIP 46 38 87 28 27 151 252 553 901 1,226
Investments 0 0 1 2,182 1 1 1 2 3 5
856 1,036 1,075 913 1,980 2,020 2,810 2,661 2,781 3,223
Total Assets 3,146 3,302 3,355 3,974 8,543 9,189 10,102 12,000 15,186 16,281

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
156 166 89 77 118 741 1,284 1,122 1,459
-104 -124 -17 -2,641 206 -764 -102 -1,253 -1,614
-48 -48 -74 2,353 191 -294 -289 -264 -164
Net Cash Flow 4 -6 -2 -210 516 -317 893 -395 -319
Free Cash Flow 41 100 -27 -13 1 192 952 342 500
CFO/OP 135% 166% 75% 89% 15% 89% 116% 93% 96%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 53 59 78 33 53 36 27 31 36
Inventory Days 20 24 26 43 34 24 30 26 26
Days Payable 184 227 292 286 274 174 215 207 200
Cash Conversion Cycle -111 -144 -188 -210 -187 -114 -158 -149 -138
Working Capital Days -12 -24 -152 -137 -44 -24 -46 -43 -47
ROCE % 4% 6% 4% 7% 12% 15% 16% 15%

Insights

In beta
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
ALOS (Average Length of Stay)
Days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR '000
Occupancy Percentage
%
Bed Capacity (Network)
Number
Outpatient (OP) Consultations
Lakhs
Operating EBITDA per bed (Annualised)
INR Lakhs

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
23.77% 23.76% 23.76% 23.75% 23.75% 23.74% 23.74% 23.74% 23.74% 23.74% 23.74% 23.72%
51.96% 59.89% 60.39% 60.69% 57.33% 56.99% 57.29% 56.93% 54.74% 54.76% 51.80% 50.55%
19.36% 11.90% 11.40% 11.55% 14.96% 15.36% 15.14% 15.55% 17.59% 17.41% 20.03% 21.20%
4.92% 4.45% 4.45% 3.99% 3.97% 3.91% 3.84% 3.77% 3.94% 4.09% 4.43% 4.52%
No. of Shareholders 1,04,6561,11,3741,18,6351,11,3381,27,0091,36,2541,37,8561,40,0281,51,6331,62,1191,80,8912,03,837

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls